# Unilateral Photopsia: An Unusual Case of Syphilitic Endophthalmitis

**Authors:** Ahmed Qaedi, Sarika Mullapudi, Tarek Persaud, Ali Hassoun

PMC · DOI: 10.7759/cureus.83984 · Cureus · 2025-05-12

## TL;DR

A 66-year-old man with unexplained vision loss was diagnosed with syphilitic endophthalmitis and showed improvement after penicillin treatment.

## Contribution

This case highlights the importance of considering syphilis in diagnosing unexplained visual acuity changes.

## Key findings

- The patient's symptoms resolved after penicillin treatment, confirming syphilitic endophthalmitis.
- Initial treatments like vitreous aspiration and antibiotics failed to improve symptoms.
- Positive syphilis serologies and RPR titer were key diagnostic indicators.

## Abstract

Syphilitic endophthalmitis represents a rare ocular manifestation that can occur in both immunocompetent and immunocompromised patients. It is often misdiagnosed due to its resemblance to many other infectious, inflammatory, malignant, and rheumatologic conditions. This report describes the case of a 66-year-old male patient who presented with visualizing bright lights in the left eye associated with a significant decline in visual acuity. A series of investigations was done, including a temporal artery biopsy with unremarkable findings. Furthermore, vitreous aspiration was performed with Gram stain revealing trace gram-positive cocci with negative culture results. Intra-vitreal vancomycin and ceftazidime were given with no symptomatic improvements. On the other hand, the serum rapid plasma reagin (RPR) titer was 1:128 with positive syphilis serologies. The patient was started on penicillin-G 4 million units intravenously every four hours for two weeks, followed by benzyl-penicillin 2.4 million units intramuscularly weekly for three weeks. Significant improvement in visual acuity was noted after completion of antibiotic therapy, with routine retinal screening demonstrating resolution of hypopyon. This case illustrates the importance of screening for syphilis in patients with unexplained changes in visual acuity, as prompt identification of syphilis and initiation of treatment are associated with favorable outcomes.

## Linked entities

- **Chemicals:** vancomycin (PubChem CID 14969), ceftazidime (PubChem CID 5481173), penicillin-G (PubChem CID 5904), benzyl-penicillin (PubChem CID 5904)

## Full-text entities

- **Diseases:** inflammatory (MESH:D007249), rheumatologic (MESH:D012216), Photopsia (MESH:C000726607), Syphilitic Endophthalmitis (MESH:D009877), decline in visual acuity (MESH:D014786), syphilis (MESH:D013587)
- **Chemicals:** vancomycin (MESH:D014640), benzyl-penicillin (MESH:D010400), ceftazidime (MESH:D002442)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12158841/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12158841/full.md

## References

18 references — full list in the complete paper: https://tomesphere.com/paper/PMC12158841/full.md

---
Source: https://tomesphere.com/paper/PMC12158841